Kolloch RE - Search Results

1

Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.

Sica D, Gradman AH, Lederballe O, Kolloch RE, Zhang J, Keefe DL. Sica D, et al. Among authors: kolloch re. Clin Drug Investig. 2011 Dec 1;31(12):825-37. doi: 10.1007/BF03256921. Clin Drug Investig. 2011. PMID: 22035463 Clinical Trial.

2

Antihypertensive effects of valsartan/hydrochlorothiazide combination in essential hypertension.

Schmidt A, Adam SA, Kolloch R, Weidinger G, Handrock R. Schmidt A, et al. Blood Press. 2001;10(4):230-7. doi: 10.1080/08037050152669756. Blood Press. 2001. PMID: 11800062 Clinical Trial.

3

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.

Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H; OTELLOH Study Group. Neutel JM, et al. Among authors: kolloch re. J Hum Hypertens. 2003 Aug;17(8):569-75. doi: 10.1038/sj.jhh.1001592. J Hum Hypertens. 2003. PMID: 12874615 Clinical Trial.

4

[Hypertension 2001].

Kolloch RE. Kolloch RE. Dtsch Med Wochenschr. 2001 Nov 23;126(47):1321. doi: 10.1055/s-2001-18561. Dtsch Med Wochenschr. 2001. PMID: 11719855 German. No abstract available.

5

Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

Stumpe KO, Overlack A, Kolloch R, Schreyer S. Stumpe KO, et al. Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):121S-126S. doi: 10.1111/j.1365-2125.1982.tb02068.x. Br J Clin Pharmacol. 1982. PMID: 6291563 Free PMC article.

6

[Arterial hypertension, antihypertensive therapy, and visit-to-visit blood pressure variability of elderly nursing home residents].

Könner F, Kuhnert R, Budnick A, Kolloch R, Scholze J, Dräger D, Kreutz R. Könner F, et al. Dtsch Med Wochenschr. 2014 Nov;139(48):2441-7. doi: 10.1055/s-0034-1387422. Epub 2014 Nov 19. Dtsch Med Wochenschr. 2014. PMID: 25409401 German.

7

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, Larochelle P, McInnes GT, Mallion JM, Ruilope L, Wedel H. Zanchetti A, et al. J Hypertens. 2001 Jun;19(6):1149-59. doi: 10.1097/00004872-200106000-00021. J Hypertens. 2001. PMID: 11403365 Clinical Trial.

8

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.

Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL. Williams GH, et al. Among authors: kolloch re. Am J Cardiol. 2004 Apr 15;93(8):990-6. doi: 10.1016/j.amjcard.2004.01.007. Am J Cardiol. 2004. PMID: 15081441 Clinical Trial.

9

Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.

Kolloch RE, Mehlburger L, Schumacher H, Göbel BO. Kolloch RE, et al. Clin Auton Res. 1993 Dec;3(6):373-8. doi: 10.1007/BF01829456. Clin Auton Res. 1993. PMID: 8193524 Clinical Trial.

10

[The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].

Kolloch RE, Rahn KH. Kolloch RE, et al. Dtsch Med Wochenschr. 1998 Jan 2;123(1-2):1-5. doi: 10.1055/s-2007-1023890. Dtsch Med Wochenschr. 1998. PMID: 9465848 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page